Tag: VERAXA Biotech
-
AI Models Enable Breakthroughs in Drug Repurposing Strategies
Miles Wang, an OpenAI researcher, is launching a startup focused on leveraging AI to repurpose existing drugs, potentially accelerating drug discovery and reducing costs. This approach utilizes AI models to analyze complex datasets for novel therapeutic applications, paving the way for faster, more efficient drug development. Read more
-
AI-Driven Innovations Accelerate India’s Novel Drug Discovery Landscape
India’s life sciences sector is rapidly transforming through AI-driven innovations in drug discovery, highlighted in a recent report by BCG and HealthKois. The integration of AI technologies is accelerating the development of novel therapeutics and positioning India as a potential leader in global pharmaceutical innovation. Read more
-
AI Collaboration Advances Precision Cancer Therapy Development
A new collaboration between Ardigen and VERAXA Biotech aims to enhance cancer therapies by optimizing target selection using advanced AI techniques. This partnership could significantly improve treatment efficacy while minimizing toxicity, marking a pivotal moment in the application of AI in cancer drug development. Read more
-
AI-Driven Precision Oncology: Enhancing Cancer Therapy Development
Ardigen and VERAXA Biotech are collaborating to enhance precision oncology through AI-driven drug discovery, optimizing cancer target selection for T cell engagers and antibody-drug conjugates. This partnership aims to minimize toxicities and improve success rates in cancer therapies. Read more
